Protein kinases: evolution of dynamic regulatory proteins

SS Taylor, AP Kornev - Trends in biochemical sciences, 2011 - cell.com
Eukayotic protein kinases evolved as a family of highly dynamic molecules with strictly
organized internal architecture. A single hydrophobic F-helix serves as a central scaffold for …

How many drug targets are there?

JP Overington, B Al-Lazikani, AL Hopkins - Nature reviews Drug …, 2006 - nature.com
For the past decade, the number of molecular targets for approved drugs has been debated.
Here, we reconcile apparently contradictory previous reports into a comprehensive survey …

Compound–protein interaction prediction with end-to-end learning of neural networks for graphs and sequences

M Tsubaki, K Tomii, J Sese - Bioinformatics, 2019 - academic.oup.com
Motivation In bioinformatics, machine learning-based methods that predict the compound–
protein interactions (CPIs) play an important role in the virtual screening for drug discovery …

Exploration of type II binding mode: A privileged approach for kinase inhibitor focused drug discovery?

Z Zhao, H Wu, L Wang, Y Liu, S Knapp, Q Liu… - ACS chemical …, 2014 - ACS Publications
The ATP site of kinases displays remarkable conformational flexibility when accommodating
chemically diverse small molecule inhibitors. The so-called activation segment, whose …

Rational design of inhibitors that bind to inactive kinase conformations

Y Liu, NS Gray - Nature chemical biology, 2006 - nature.com
The majority of kinase inhibitors that have been developed so far—known as type I inhibitors—
target the ATP binding site of the kinase in its active conformation, in which the activation …

[图书][B] Biomolecular crystallography: principles, practice, and application to structural biology

B Rupp - 2009 - taylorfrancis.com
Synthesizing over thirty years of advances into a comprehensive textbook, Biomolecular
Crystallography describes the fundamentals, practices, and applications of protein …

Discovery of potent and selective covalent inhibitors of JNK

T Zhang, F Inesta-Vaquera, M Niepel, J Zhang… - Chemistry & biology, 2012 - cell.com
The mitogen-activated kinases JNK1/2/3 are key enzymes in signaling modules that
transduce and integrate extracellular stimuli into coordinated cellular response. Here, we …

Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT

P Dubreuil, S Letard, M Ciufolini, L Gros, M Humbert… - PloS one, 2009 - journals.plos.org
Background The stem cell factor receptor, KIT, is a target for the treatment of cancer,
mastocytosis, and inflammatory diseases. Here, we characterise the in vitro and in vivo …

Can we rationally design promiscuous drugs?

AL Hopkins, JS Mason, JP Overington - Current opinion in structural biology, 2006 - Elsevier
Structure-based drug design is now used widely in modern medicinal chemistry. The
application of structural biology to medicinal chemistry has heralded the 'rational drug …

The Src, Syk, and Tec family kinases: distinct types of molecular switches

JM Bradshaw - Cellular signalling, 2010 - Elsevier
The Src, Syk, and Tec family kinases are three of the most well characterized tyrosine kinase
families found in the human genome. Members of these kinase families function …